Considering ANGPTL-4 is a major molecular mediator of nephrotic syndrome, it has been identified as an ideal candidate for the treatment of proteinuric disorders caused by chronic kidney disease [20]. This evidence concerns the gene ANGPTL4 and nephrotic syndrome.